Perspective Therapeutics (CATX) Current Assets (2016 - 2025)

Historic Current Assets for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $178.5 million.

  • Perspective Therapeutics' Current Assets fell 3393.1% to $178.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.5 million, marking a year-over-year decrease of 3393.1%. This contributed to the annual value of $231.2 million for FY2024, which is 127292.87% up from last year.
  • As of Q3 2025, Perspective Therapeutics' Current Assets stood at $178.5 million, which was down 3393.1% from $196.0 million recorded in Q2 2025.
  • Over the past 5 years, Perspective Therapeutics' Current Assets peaked at $294.2 million during Q2 2024, and registered a low of $16.8 million during Q4 2023.
  • Over the past 5 years, Perspective Therapeutics' median Current Assets value was $65.0 million (recorded in 2021), while the average stood at $114.8 million.
  • Per our database at Business Quant, Perspective Therapeutics' Current Assets plummeted by 6836.04% in 2023 and then soared by 127292.87% in 2024.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Current Assets stood at $63.6 million in 2021, then dropped by 16.33% to $53.2 million in 2022, then tumbled by 68.36% to $16.8 million in 2023, then skyrocketed by 1272.93% to $231.2 million in 2024, then fell by 22.78% to $178.5 million in 2025.
  • Its Current Assets was $178.5 million in Q3 2025, compared to $196.0 million in Q2 2025 and $215.7 million in Q1 2025.